---
document_datetime: 2023-09-21 22:07:35
document_pages: 9
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/levetiracetam-actavis-group-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: levetiracetam-actavis-group-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.1016997
conversion_datetime: 2025-12-21 16:06:08.591016
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Levetiracetam Actavis Group

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0029              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 21/06/2023                          |                                             | SmPC and PL                      |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IG/1612   | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                            | 31/05/2023   |            | SmPC, Labelling and PL   |         |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|--------------------------|---------|
| IA/0027   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                           | 22/03/2023   | n/a        |                          |         |
| IB/0026   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                  | 29/06/2022   | 23/05/2023 | SmPC, Labelling and PL   | the MAH |
| IB/0025   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                          | 25/05/2021   | 21/06/2021 | SmPC and PL              |         |
| IA/0024/G | This was an application for a group of variations. B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change | 16/04/2021   | n/a        |                          |         |

<div style=\"page-break-after: always\"></div>

|           | comply with an update of the relevant monograph the Ph. Eur. or national pharmacopoeia of a State                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |            |             | to of Member   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|----------------|
| IB/0023/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 22/12/2020 | 21/06/2021 | SmPC and PL | the MAH        |
| IAIN/0022 | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking                                                                                                                                                                                                                                                                                                                                                                                  | 09/04/2020 | n/a        |             |                |
| IB/0021   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                         | 22/01/2020 | 24/09/2020 | SmPC and PL |                |

<div style=\"page-break-after: always\"></div>

| IB/0020   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                         | 11/09/2019   | 24/09/2020   | SmPC and PL            |                 |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|-----------------|
| IA/0019/G | This was an application for a group of variations. B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate | 31/05/2019   | n/a          |                        | from an already |
| IB/0018   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                         | 09/10/2018   | 13/09/2019   | SmPC, Labelling and PL |                 |
| N/0017    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                     | 20/03/2018   | 13/09/2019   | PL                     |                 |
| IA/0016   | B.III.1.a.2 - Submission of a new/updated or                                                                                                                                                                                                                                                                                                                                                                                                         | 19/01/2018   | n/a          |                        |                 |

<div style=\"page-break-after: always\"></div>

|           | deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                               |            |            |                                  |                                                                                                                                                                                                                                                                                           |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0015   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 20/01/2017 | 23/10/2017 | SmPC and PL                      |                                                                                                                                                                                                                                                                                           |
| IAIN/0014 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                               | 28/11/2016 | 23/10/2017 | PL                               |                                                                                                                                                                                                                                                                                           |
| R/0012    | Renewal of the marketing authorisation.                                                                                                                                                                                                                      | 23/06/2016 | 08/08/2016 | SmPC, Labelling and PL           | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Levetiracetam Actavis Group in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IAIN/0013 | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a new manufacturer (replacement or addition)                                                          | 24/06/2016 | n/a        |                                  |                                                                                                                                                                                                                                                                                           |
| IB/0011   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 08/03/2016 | 08/08/2016 | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

| IB/0009/G   | This was an application for a group of variations. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) B.II.f.1.b.2 - Stability of FP - Extension of the shelf life of the finished product - After first opening (supported by real time data)   | 16/12/2015   | 08/08/2016   | SmPC, Labelling and PL   |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|
| IAIN/0010   | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                                                                                                 | 17/11/2015   | n/a          |                          |
| N/0008      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                        | 07/09/2015   | 08/08/2016   | PL                       |
| IAIN/0007   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                         | 20/05/2015   | n/a          |                          |
| N/0006      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                        | 06/02/2015   | 08/08/2016   | PL                       |
| IA/0005/G   | This was an application for a group of variations. B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products                                                                                                                                                       | 21/05/2014   | n/a          |                          |

<div style=\"page-break-after: always\"></div>

|           | - Change in test procedure for the finished - Minor changes to an approved test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |             | B.II.d.2.a product procedure                                                                                |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-------------------------------------------------------------------------------------------------------------|
| IB/0004/G | This was an application for a group of variations. To update the SmPC and package leaflet with the tabulated list of adverse reactions in section 4.8 with 'hyponatraemia' and in section 4 of the PIL including 'decreased blood sodium concentration'. To update 4.8 of the SmPC to include 'drug reaction with eosinophilia and systematic symptoms (DRESS)' as a rare adverse drug reaction. The package leaflet was updated accordingly. All changes have been made in line with the originator product. In addition the contact details of the local representatives in BE, CZ, CY, LU and EL were updated in the package leaflet. Furthermore minor changes in the DK, EL, FI, HR, HU, IT, LV, PL and RO Product Informations (PI) have been keep the PI in line with the originator | 16/04/2014 | 15/12/2014 | SmPC and PL | performed to product. C.I.2.a - Change generic/hybrid/biosimilar assessment of the product - Implementation |

<div style=\"page-break-after: always\"></div>

|         | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0003 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   | 19/12/2013 | 15/12/2014 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| N/0002  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                               | 25/09/2013 | 15/12/2014 | PL                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| IB/0001 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                 | 06/09/2012 | 29/10/2012 | SmPC, Labelling and PL | Following CHMP adoption of safety variations to the Marketing Authorisations for Keppra, dated 19 April 2012 section 4.8 of the SmPC for Levetiracetam Actavis Group was updated in order to add 'panic attack' as an undesirable effect. The Package Leaflet was updated in accordance. Moreover, the description of pancytopenia, erythema multiforme, Stevens-Johnsons syndrome and toxic epidermal necrolysis in section 4 of the Package Leaflet was also updated. The PI was brought in line with the latest QRD template, version 8. Additionally, local contact details for Netherlands, Greece, Poland and Slovenia have been updated. |